Potent Functional Immunogenicity of Plasmodium falciparum Transmission-Blocking Antigen (Pfs25) Delivered with Nanoemulsion and Porous Polymeric Nanoparticles

Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial

The Lancet · 2015 · 1.5K citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +16

Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model

Camilla Foged, Birger Brodin, Anne Sundblad · International Journal of Pharmaceutics · 2005 · 885 citations

Life Sciences, Cell Biology, Immunology +16

Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial.

Emmanuel B. Bache, Sélidji Todagbé Agnandji, Bertrand Lell et al. · The Lancet · 2015 · 671 citations

Veterinary Medicine, Infectious Diseases, Pediatrics +16

Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51

Yimin Wu, Ruth D. Ellis, Donna Shaffer et al. · PLoS ONE · 2008 · 454 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +13

A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains

David C. Kaslow, Isabella A. Quakyi, Chiang Syin et al. · Nature · 1988 · 376 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17